Deciphering the involvement of the Hippo pathway co-regulators, YAP/TAZ in invadopodia formation and matrix degradation

Jubina Balan Venghateri, Bareket Dassa, David Morgenstern, Michal Shreberk-Shaked, Moshe Oren, Benjamin Geiger*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

Invadopodia are adhesive, actin-rich protrusions formed by metastatic cancer cells that degrade the extracellular matrix and facilitate invasion. They support the metastatic cascade by a spatially and temporally coordinated process whereby invading cells bind to the matrix, degrade it by specific metalloproteinases, and mechanically penetrate diverse tissue barriers by forming actin-rich extensions. However, despite the apparent involvement of invadopodia in the metastatic process, the molecular mechanisms that regulate invadopodia formation and function are still largely unclear. In this study, we have explored the involvement of the key Hippo pathway co-regulators, namely YAP, and TAZ, in invadopodia formation and matrix degradation. Toward that goal, we tested the effect of depletion of YAP, TAZ, or both on invadopodia formation and activity in multiple human cancer cell lines. We report that the knockdown of YAP and TAZ or their inhibition by verteporfin induces a significant elevation in matrix degradation and invadopodia formation in several cancer cell lines. Conversely, overexpression of these proteins strongly suppresses invadopodia formation and matrix degradation. Proteomic and transcriptomic profiling of MDA-MB-231 cells, following co-knockdown of YAP and TAZ, revealed a significant change in the levels of key invadopodia-associated proteins, including the crucial proteins Tks5 and MT1-MMP (MMP14). Collectively, our findings show that YAP and TAZ act as negative regulators of invadopodia formation in diverse cancer lines, most likely by reducing the levels of essential invadopodia components. Dissecting the molecular mechanisms of invadopodia formation in cancer invasion may eventually reveal novel targets for therapeutic applications against invasive cancer.
Original languageEnglish
Article number290
JournalCell Death and Disease
Volume14
Issue number4
DOIs
Publication statusPublished - Apr 2023

Bibliographical note

Funding Information:
We thank the scientific staff at the Department of Life Sciences Core facilities, Weizmann Institute of Science (WIS), for the access to the research infrastructure used in this study, and for their competent help. We are particularly grateful to Dr. Yishai Levin at The De Botton Protein Profiling Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine (G-INCPM), WIS, for the scientific input, guidance and help in the proteomic profiling. We are grateful to the Crown Genomics institute of the G-INCPM, WIS, for their assistance in RNA sequencing. We also thank Dr. Shlomit Reich-Zeliger (Prof. Nir Friedman Lab) for assistance with some of the reagents and access to instruments used for RNA quantitation and quality assessment of RNA samples for the RNA sequencing experiments in this study. This study was supported by grants from the Minerva Center for Aging, and a Precision Medicine grant from the Israel Science Foundation.

Funding Information:
We thank the scientific staff at the Department of Life Sciences Core facilities, Weizmann Institute of Science (WIS), for the access to the research infrastructure used in this study, and for their competent help. We are particularly grateful to Dr. Yishai Levin at The De Botton Protein Profiling Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine (G-INCPM), WIS, for the scientific input, guidance and help in the proteomic profiling. We are grateful to the Crown Genomics institute of the G-INCPM, WIS, for their assistance in RNA sequencing. We also thank Dr. Shlomit Reich-Zeliger (Prof. Nir Friedman Lab) for assistance with some of the reagents and access to instruments used for RNA quantitation and quality assessment of RNA samples for the RNA sequencing experiments in this study. This study was supported by grants from the Minerva Center for Aging, and a Precision Medicine grant from the Israel Science Foundation.

Publisher Copyright:
© 2023, The Author(s).

All Science Journal Classification (ASJC) codes

  • Immunology
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Deciphering the involvement of the Hippo pathway co-regulators, YAP/TAZ in invadopodia formation and matrix degradation'. Together they form a unique fingerprint.

Cite this